Irritable bowel syndrome, chronic itching, asthma and migraine are in many cases hard-to-treat conditions. They have in common that they are triggered by an excessive immune response — which in severe cases can be life-threatening. A team of researchers has now identified a promising bioactive compound that could effectively reduce symptoms and slash fatality risk. The compound blocks a receptor on certain defense cells, thus preventing a derailed immune response.
Quelle: ScienceDaily | Allergy
Titelbild/Grafik: ScienceDaily News
Weiteres von ScienceDaily | Allergy
- Vitamin A may be helping cancer hide from the immune system
- Long COVID may be fueled by inflammation and tiny clots
- A global cancer surge is underway and the world is not ready
- MIT scientists find a way to rejuvenate the immune system as we age
- Stanford scientists uncover why mRNA COVID vaccines can trigger heart inflammation
- Eating more vitamin C can physically change your skin
- ADHD drugs don’t work the way we thought
- A new drug could stop Alzheimer’s before memory loss begins
- Study links full-fat cheese to lower dementia risk
- He ate a hamburger and died hours later. Doctors found a shocking cause
Möchten Sie zu diesem Inhalt ein Kommentar abgeben oder haben Sie dazu eine Frage, dann machen Sie dies bitte immer auf der Herausgeberseite!
